Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025)
Prestige Consumer Healthcare (PBH) posted quarterly FCF Margin of 26.55% for Q4 2025, up 467.0% year-over-year from 4.68% in Q4 2024, and up 31.41% quarter-over-quarter from 20.2% in Q3 2025.
Prestige Consumer Healthcare (PBH) FCF Margin (2010 - 2025) Analysis & Trends
Prestige Consumer Healthcare's FCF Margin history runs 16 years deep, the most recent figure standing at 26.55% for Q4 2025.
- In Q4 2025, FCF Margin rose 467.0% year-over-year to 26.55%; the TTM figure through Dec 2025 stood at 24.21% (up 197.0% YoY), while the FY2025 annual figure was 21.38%, up 11.0% from the prior year.
- FCF Margin for Q4 2025 stood at 26.55%, up from 20.2% in the prior quarter.
- The five-year high for FCF Margin was 31.33% in Q2 2025, with the low at 16.69% in Q2 2023.
- The 5-year median for FCF Margin is 21.52% (2024), against an average of 22.12%.
- The sharpest annual moves came in 2021 and 2025: FCF Margin plunged 646 bps in 2021, then soared 1126 bps in 2025.
- Prestige Consumer Healthcare's FCF Margin stood at 23.34% in 2021, then declined by 17 bps to 19.29% in 2022, then advanced by 27 bps to 24.57% in 2023, then retreated by 11 bps to 21.88% in 2024, then rose by 21 bps to 26.55% in 2025.
- Business Quant data shows PBH's FCF Margin at 26.55% in Q4 2025, 20.2% in Q3 2025, and 31.33% in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | 7.41% |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | 21.80% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 14.87% |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | 26.25% |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | 8.76% |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | 13.41% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 17.84% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.43 Bn | 2.37 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 26.55% |
| Sep 30, 2025 | 20.20% |
| Jun 30, 2025 | 31.33% |
| Mar 31, 2025 | 19.68% |
| Dec 31, 2024 | 21.88% |
| Sep 30, 2024 | 23.88% |
| Jun 30, 2024 | 20.07% |
| Mar 31, 2024 | 23.02% |
| Dec 31, 2023 | 24.57% |
| Sep 30, 2023 | 20.79% |
| Jun 30, 2023 | 16.69% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 19.29% |
| Sep 30, 2022 | 19.07% |
| Jun 30, 2022 | 20.65% |
| Mar 31, 2022 | 22.46% |
| Dec 31, 2021 | 23.34% |
| Sep 30, 2021 | 21.16% |
| Jun 30, 2021 | 25.19% |
| Mar 31, 2021 | 22.79% |